0001104659-14-074429.txt : 20141028 0001104659-14-074429.hdr.sgml : 20141028 20141028171122 ACCESSION NUMBER: 0001104659-14-074429 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20141028 DATE AS OF CHANGE: 20141028 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Ophthotech Corp. CENTRAL INDEX KEY: 0001410939 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-87636 FILM NUMBER: 141177898 BUSINESS ADDRESS: STREET 1: ONE PENN PLAZA STREET 2: 19TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10119 BUSINESS PHONE: 212-845-8200 MAIL ADDRESS: STREET 1: ONE PENN PLAZA STREET 2: 19TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10119 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: HBM Healthcare Investments (Cayman) Ltd. CENTRAL INDEX KEY: 0001232258 IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: 2454 WEST BAY ROAD, 3RD FLOOR CITY: GRAND CAYMAN STATE: E9 ZIP: 00000 BUSINESS PHONE: 1 345 946 8002 MAIL ADDRESS: STREET 1: P.O BOX 30852 CITY: GRAND CAYMAN STATE: E9 ZIP: KY1-1204 FORMER COMPANY: FORMER CONFORMED NAME: HBM BIOVENTURES CAYMAN LTD DATE OF NAME CHANGE: 20030512 SC 13D/A 1 a14-23174_2sc13da.htm SC 13D/A

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

SCHEDULE 13D

 

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 3 )*

 

Ophthotech Corporation

(Name of Issuer)

 

 

 

Common Stock, $0.001 par value per share

(Title of Class of Securities)

 

 

 

683745103

 (CUSIP Number)

 

HBM Healthcare Investments (Cayman) Ltd.

Governors Square, Suite #4-212-2

23 Lime Tree Bay Ave., West Bay

Grand Cayman, Cayman Islands

Telephone:  (345) 946-8002

 (Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)

 

September 10, 2014

(Date of Event Which Requires Filing of This Statement)

 

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. o

 

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are to be sent.

 

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

 

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 



 

CUSIP No. 683745103

 

 

 

 

1.

Name of Reporting Persons

HBM Healthcare Investments (Cayman) Ltd.

2.

Check the Appropriate Box if a Member of a Group (See Instructions)

(a)

(b)

3.

SEC USE ONLY

4.

Source of Funds (See Instructions)

WC

5.

Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)

6.

Citizenship or Place of Organization

Cayman Islands, British West Indies

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person With:

7.

Sole Voting Power

1,611,036(1)

8.

Shared Voting Power

0

9.

Sole Dispositive Power

1,611,036(1)

10.

Shared Dispositive Power

0

11.

Aggregate Amount Beneficially Owned by Each Reporting Person

1,611,036(1)

12.

Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) ¨

 

13.

Percent of Class Represented by Amount in Row (11)

4.8090%(2)

14.

Type of Reporting Person (See Instructions)

CO

(1) Includes 13,670 shares of Common Stock underlying warrants which are exercisable within 60 days of the date of this filing.

 

(2) This percentage is calculated based upon 33,486,578 shares of the Issuer’s Common Stock outstanding as of July 31, 2014 as reported in Issuer’s Report on Form 10-Q filed on August 6, 2014.

 

2



 

Explanatory Note:  This Amendment No. 3 to Schedule 13D (this “Amendment No. 3”) amends and supplements the Schedule 13D previously filed with the United States Securities and Exchange Commission (the “SEC”) on October 10, 2013 (the “Original 13D” and amended by Amendment No. 1 filed May 15, 2014 and Amendment No. 2 filed June 9, 2014 (the “Schedule 13 D”).  Unless otherwise indicated, each capitalized term used but not defined herein shall have the meaning assigned to such term in the Schedule 13 D.

 

Except as specifically provided herein, this Amendment No. 3 does not modify any of the information previously reported on the Original 13D.  All capitalized terms contained herein but not otherwise defined shall have the meanings ascribed to such terms in the Original 13D.

 

Item 4.              Purpose of Transaction

 

The response set forth in Item 4 of Schedule 13D is hereby amended and supplemented by adding the following paragraph at the end of Item 4:

 

The Reporting Person sold an aggregate of 1,012,282 of Common Stock in open market transactions from June 10, 2104 through October 23, 2014 for gross proceeds of approximately $39,739,712.20.

 

Item 5.              Interest in Securities of the Issuer

 

Item 5.  Interest in Securities of the Issuer” of Schedule 13D is hereby amended and restated as follows:

 

(a) – (b) As of this date of this filing, the Reporting Person directly beneficially owns 1,597,366 shares of Common Stock and Warrants to purchase an aggregate of 13,670 shares of Common Stock, which in the aggregate, constitutes approximately 4.8090% of the Common Stock based on 33,486,578 shares of the Issuer’s Common Stock outstanding, as reported in Issuer’s annual report on Form 10-Q filed on August 6, 2014.

 

(c)                               The following is a list of the shares sold in multiple open market transactions.  Upon request, the reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the Security and Exchange Commission full information regarding shares sold at each separate price within the ranges set forth below.

 

Entity

 

Date of Transaction

 

Number of
Shares Sold

 

Price Per Share

 

HBM Healthcare Investments (Cayman) Ltd.

 

June 10, 2014

2,500

$47.00

HBM Healthcare Investments (Cayman) Ltd.

 

August 13, 2014

2,497

$40.1155

HBM Healthcare Investments (Cayman) Ltd.

 

August 13, 2014

7,476

$39.6103

 

3



 

HBM Healthcare Investments (Cayman) Ltd.

 

August 13, 2014

15,000

$39.7029

HBM Healthcare Investments (Cayman) Ltd.

 

August 14, 2014

12,503

$39.1123

HBM Healthcare Investments (Cayman) Ltd.

 

August 15, 2014

7,628

$39.5001

HBM Healthcare Investments (Cayman) Ltd.

 

August 18, 2014

22,372

$40.2828

HBM Healthcare Investments (Cayman) Ltd.

 

August 19, 2014

20,000

$39.3418

HBM Healthcare Investments (Cayman) Ltd.

 

August 20, 2014

2,300

$39.0137

HBM Healthcare Investments (Cayman) Ltd.

 

August 25, 2014

6,924

$37.6458

HBM Healthcare Investments (Cayman) Ltd.

 

August 26, 2014

12,900

$39.5715

HBM Healthcare Investments (Cayman) Ltd.

 

August 26, 2014

20,524

$39.1342

HBM Healthcare Investments (Cayman) Ltd.

 

August 26, 2014

10,776

$38.3464

HBM Healthcare Investments (Cayman) Ltd.

 

August 27, 2014

15,800

$39.1415

HBM Healthcare Investments (Cayman) Ltd.

 

August 28, 2014

133

$39.03

HBM Healthcare Investments (Cayman) Ltd.

 

August 29, 2014

6,825

$39.046

HBM Healthcare Investments (Cayman) Ltd.

 

September 2, 2014

38

$39.0405

HBM Healthcare Investments (Cayman) Ltd.

 

September 3, 2014

1,716

$38.6661

HBM Healthcare Investments (Cayman) Ltd.

 

September 4, 2014

35,766

$38.2516

HBM Healthcare Investments (Cayman) Ltd.

 

September 8, 2014

26,000

$37.8344

HBM Healthcare Investments (Cayman) Ltd.

 

September 9, 2014

32,795

$39.3273

 

4



 

HBM Healthcare Investments (Cayman) Ltd.

 

September 9, 2014

822

$39.4365

HBM Healthcare Investments (Cayman) Ltd.

 

September 10, 2014

30,000

$40.2712

HBM Healthcare Investments (Cayman) Ltd.

 

September 10, 2014

30,000

$40.3466

HBM Healthcare Investments (Cayman) Ltd.

 

September 10, 2014

23,000

$40.3952

HBM Healthcare Investments (Cayman) Ltd.

 

September 11, 2014

57,000

$40.1347

HBM Healthcare Investments (Cayman) Ltd.

 

September 12, 2014

25,000

$39.5717

HBM Healthcare Investments (Cayman) Ltd.

 

September 12, 2014

10,239

$40.0833

HBM Healthcare Investments (Cayman) Ltd.

 

September 15, 2014

1,240

$39.3057

HBM Healthcare Investments (Cayman) Ltd.

 

September 16, 2014

15,000

$39.0303

HBM Healthcare Investments (Cayman) Ltd.

 

September 16, 2014

18,521

$39.0046

HBM Healthcare Investments (Cayman) Ltd.

 

September 16, 2014

8,300

$39.0022

HBM Healthcare Investments (Cayman) Ltd.

 

September 16, 2014

7,100

$39.041

HBM Healthcare Investments (Cayman) Ltd.

 

September 17, 2014

34,600

$39.0335

HBM Healthcare Investments (Cayman) Ltd.

 

September 17, 2014

1,300

$39.3302

HBM Healthcare Investments (Cayman) Ltd.

 

September 18, 2014

12,800

$38.8646

HBM Healthcare Investments (Cayman) Ltd.

 

September 18, 2014

14,441

$39.0191

HBM Healthcare Investments (Cayman) Ltd.

 

September 19, 2014

21,459

$39.065

HBM Healthcare Investments (Cayman) Ltd.

 

September 19, 2014

12,837

$39.4857

 

5



 

HBM Healthcare Investments (Cayman) Ltd.

 

September 22, 2014

4,100

$38.6859

HBM Healthcare Investments (Cayman) Ltd.

 

September 24, 2014

13,000

$38.5165

HBM Healthcare Investments (Cayman) Ltd.

 

September 25, 2014

20,063

$38.0089

HBM Healthcare Investments (Cayman) Ltd

 

October 3, 2014

13,319

$38.6162

HBM Healthcare Investments (Cayman) Ltd

 

October 7, 2014

16,600

$37.6879

HBM Healthcare Investments (Cayman) Ltd

 

October 8, 2014

11,337

$38.5538

HBM Healthcare Investments (Cayman) Ltd

 

October 8, 2014

8,600

$38.5676

HBM Healthcare Investments (Cayman) Ltd

 

October 9, 2014

25,000

$38.1181

HBM Healthcare Investments (Cayman) Ltd

 

October10, 2014

20,147

$38.0794

HBM Healthcare Investments (Cayman) Ltd

 

October 13, 2014

1,000

$38.5025

HBM Healthcare Investments (Cayman) Ltd

 

October 14, 2014

719

$38.7142

HBM Healthcare Investments (Cayman) Ltd

 

October 15, 2014

10,000

$37.6015

HBM Healthcare Investments (Cayman) Ltd

 

October 15, 2014

15,000

$38.0274

HBM Healthcare Investments (Cayman) Ltd

 

October 16, 2014

100,000

$39.8605

HBM Healthcare Investments (Cayman) Ltd

 

October 17, 2014

25,000

$40.5000

HBM Healthcare Investments (Cayman) Ltd

 

October 17, 2014

15,200

$40.1878

HBM Healthcare Investments (Cayman) Ltd

 

October 17, 2014

19,400

$40.5023

HBM Healthcare Investments (Cayman) Ltd

 

October 20, 2014

50,000

$39.1053

HBM Healthcare Investments (Cayman) Ltd

 

October 21, 2014

6,000

$40.5023

HBM Healthcare Investments (Cayman) Ltd

 

October 22, 2014

4,300

$40.0149

HBM Healthcare Investments (Cayman) Ltd

 

October 22, 2014

15,300

$39.637

 

6



 

HBM Healthcare Investments (Cayman) Ltd

 

October 23, 2014

8,037

$39.9351

HBM Healthcare Investments (Cayman) Ltd

 

October 23, 2014

24,028

$39.7041

 

7



 

Signatures

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

 

Date:  October 27, 2014

HBM HEALTHCARE INVESTMENTS (CAYMAN) LTD.

 

 

 

 

 

 

 

By:

/s/ Jean-Marc Lesieur

 

Name:  Jean-Marc Lesieur

 

Title:  Director